Aberle, J., Menzen, M., Schmid, S. M., Terkamp, C., Jaeckel, E., Rohwedder, K., . . . Birkenfeld, A. L. (2020). Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes. Nature Portfolio.
Cita Chicago Style (17a ed.)Aberle, Jens, et al. Dapagliflozin Effects on Haematocrit, Red Blood Cell Count and Reticulocytes in Insulin-treated Patients with Type 2 Diabetes. Nature Portfolio, 2020.
Cita MLA (8a ed.)Aberle, Jens, et al. Dapagliflozin Effects on Haematocrit, Red Blood Cell Count and Reticulocytes in Insulin-treated Patients with Type 2 Diabetes. Nature Portfolio, 2020.
Precaución: Estas citas no son 100% exactas.